GLP Watchdog

Hers vs KairoRx

Hers has an open FDA warning letter dated September 9, 2025. KairoRx has none. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at KairoRx.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / KairoRx

Hers logo

Hers

6.8/10

KairoRx logo

KairoRx

7.0/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit HersFull review
Visit KairoRxFull review

Neither Hers nor KairoRx pays us. Links to them earn nothing. Scores: Hers 6.8, KairoRx 7.0. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. KairoRx has none.

  2. 02

    Hers names three pharmacies. KairoRx names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at KairoRx.

  4. 04

    Only Hers lists a price for brand-name tirzepatide pen. Only KairoRx lists a price for compounded tirzepatide injection.

  5. 05

    Hers lists all 50 states. KairoRx publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

KairoRx

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection
Not sold or not priced

$349/mo

$4,188 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Price includes
Medication
Clinician visits, shipping, coaching
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Month-to-month, or quarterly at a lower rate; plans continue until canceled from the account
Refunds
No refund guaranteed once the pharmacy has processed an order
Not charged unless approved. Full refund within 14 days of the first charge if the pharmacy has not prepared the medication; none once it is prepared.

Read off each seller’s own pages. Hers: September 28, 2026. KairoRx: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which KairoRx does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for KairoRx

7.0/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits and coaching
  • Names no compounding pharmacy
  • Publishes no state list
Visit KairoRx

Scores

Hers 6.8 · KairoRx 7.0 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

3.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs KairoRx: questions

Hers has an open FDA warning letter dated September 9, 2025. KairoRx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. KairoRx names no compounding pharmacy in our record.
Neither, by more than $1 a month. Hers charges $199 a month and KairoRx $199 a month.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. KairoRx states you can cancel at any time; refunds: not charged unless approved. full refund within 14 days of the first charge if the pharmacy has not prepared the medication; none once it is prepared.
Neither Hers nor KairoRx pays us. Links to them earn nothing. Scores: Hers 6.8, KairoRx 7.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks